Eli Lilly - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

Lilly initiates real-world study of migraine drug Emgality

Eli Lilly
Lilly received the FDA approval for Emgality to prevent migraine and treat episodic cluster headache. Credit: Paul Sableman.